Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study

Objective: In comparison to current standard photon irradiation, proton therapy (PT) significantly reduces dose to the surrounding normal tissue and therefore is expected to reduce toxicity and improve health related quality of life (HRQoL). Despite the high expectations of PT, there is very limited...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot, Hedwig M. Blommestein
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630825000035
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582156728139776
author Yi Hsuan Chen
Michiel Kroesen
Mischa Hoogeman
Matthijs Versteegh
Carin Uyl-de Groot
Hedwig M. Blommestein
author_facet Yi Hsuan Chen
Michiel Kroesen
Mischa Hoogeman
Matthijs Versteegh
Carin Uyl-de Groot
Hedwig M. Blommestein
author_sort Yi Hsuan Chen
collection DOAJ
description Objective: In comparison to current standard photon irradiation, proton therapy (PT) significantly reduces dose to the surrounding normal tissue and therefore is expected to reduce toxicity and improve health related quality of life (HRQoL). Despite the high expectations of PT, there is very limited data on patients’ HRQoL after radiotherapy. This study evaluated HRQoL in head and neck cancer (HNC) patients receiving PT and established a robust benchmark for future comparison of PT and the radiotherapy advancements. Method: A questionnaire-based (consisting of EORTC-QLQ-C30, EQ-5D, and EORTC-H&N-35) prospective cohort study was performed in a Dutch proton therapy center. HNC patients who received PT between January 2020 to December 2022 were enrolled in this study. The questionnaires were distributed pre-treatment, and 0, 6, 12, 24 months post-treatment. The generalized estimating equations method was used to analyze the utility change and negative impact of the radiation-related toxicities. Results: 119 HNC patients were included in the study. Symptom and function scores showed the deterioration of all reported functions during the period of treatment. Most of the functions recovered within six months and improved beyond baseline. At the end of PT, the patients’ utility decreased significantly (0.12 points) compared to the baseline. The loss in utility was recovered after six months and a further improvement was seen one year after the treatment. This study further provided the estimation of the disutility of each radiation related toxicity. Conclusion: The present study presented the impact of toxicity on patient’s utility over time and further confirmed it with the results of patient-reported symptom and function. This study provided estimation of each radiation-related toxicity, including xerostomia, dysphagia, mucositis, and dermatitis, which could contribute to the value assessment through economic evaluations of PT.
format Article
id doaj-art-42f1672fb577405191b3db5552d8f3dd
institution Kabale University
issn 2405-6308
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Clinical and Translational Radiation Oncology
spelling doaj-art-42f1672fb577405191b3db5552d8f3dd2025-01-30T05:14:29ZengElsevierClinical and Translational Radiation Oncology2405-63082025-03-0151100913Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal studyYi Hsuan Chen0Michiel Kroesen1Mischa Hoogeman2Matthijs Versteegh3Carin Uyl-de Groot4Hedwig M. Blommestein5Erasmus School of Health Policy & Management Erasmus University Rotterdam Rotterdam the Netherlands; Corresponding author at: Burgemeester Oudlaan 50, 3062 PA Rotterdam, the Netherlands.Department of Medical Physics and Informatics HollandPTC Delft the Netherlands; Department of Radiotherapy Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the NetherlandsDepartment of Medical Physics and Informatics HollandPTC Delft the Netherlands; Department of Radiotherapy Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the NetherlandsInstitute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50 3062 PA Rotterdam, the NetherlandsErasmus School of Health Policy & Management Erasmus University Rotterdam Rotterdam the NetherlandsErasmus School of Health Policy & Management Erasmus University Rotterdam Rotterdam the NetherlandsObjective: In comparison to current standard photon irradiation, proton therapy (PT) significantly reduces dose to the surrounding normal tissue and therefore is expected to reduce toxicity and improve health related quality of life (HRQoL). Despite the high expectations of PT, there is very limited data on patients’ HRQoL after radiotherapy. This study evaluated HRQoL in head and neck cancer (HNC) patients receiving PT and established a robust benchmark for future comparison of PT and the radiotherapy advancements. Method: A questionnaire-based (consisting of EORTC-QLQ-C30, EQ-5D, and EORTC-H&N-35) prospective cohort study was performed in a Dutch proton therapy center. HNC patients who received PT between January 2020 to December 2022 were enrolled in this study. The questionnaires were distributed pre-treatment, and 0, 6, 12, 24 months post-treatment. The generalized estimating equations method was used to analyze the utility change and negative impact of the radiation-related toxicities. Results: 119 HNC patients were included in the study. Symptom and function scores showed the deterioration of all reported functions during the period of treatment. Most of the functions recovered within six months and improved beyond baseline. At the end of PT, the patients’ utility decreased significantly (0.12 points) compared to the baseline. The loss in utility was recovered after six months and a further improvement was seen one year after the treatment. This study further provided the estimation of the disutility of each radiation related toxicity. Conclusion: The present study presented the impact of toxicity on patient’s utility over time and further confirmed it with the results of patient-reported symptom and function. This study provided estimation of each radiation-related toxicity, including xerostomia, dysphagia, mucositis, and dermatitis, which could contribute to the value assessment through economic evaluations of PT.http://www.sciencedirect.com/science/article/pii/S2405630825000035Proton therapyHead and neck cancerQuality of lifeHealth-related quality of lifeRadiotherapy-related toxicity
spellingShingle Yi Hsuan Chen
Michiel Kroesen
Mischa Hoogeman
Matthijs Versteegh
Carin Uyl-de Groot
Hedwig M. Blommestein
Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
Clinical and Translational Radiation Oncology
Proton therapy
Head and neck cancer
Quality of life
Health-related quality of life
Radiotherapy-related toxicity
title Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
title_full Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
title_fullStr Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
title_full_unstemmed Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
title_short Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study
title_sort treatment related toxicity utility and patient reported outcomes of head and neck cancer patients treated with proton therapy a longitudinal study
topic Proton therapy
Head and neck cancer
Quality of life
Health-related quality of life
Radiotherapy-related toxicity
url http://www.sciencedirect.com/science/article/pii/S2405630825000035
work_keys_str_mv AT yihsuanchen treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy
AT michielkroesen treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy
AT mischahoogeman treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy
AT matthijsversteegh treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy
AT carinuyldegroot treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy
AT hedwigmblommestein treatmentrelatedtoxicityutilityandpatientreportedoutcomesofheadandneckcancerpatientstreatedwithprotontherapyalongitudinalstudy